BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8163032)

  • 21. Premature closure of the ductus arteriosus: variable response among monozygotic twins after in utero exposure to indomethacin.
    Shehata BM; Bare JB; Denton TD; Habib MN; Black JO
    Fetal Pediatr Pathol; 2006; 25(3):151-7. PubMed ID: 17060191
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized trial of oral indomethacin and terbutaline sulfate for the long-term suppression of preterm labor.
    Bivins HA; Newman RB; Fyfe DA; Campbell BA; Stramm SL
    Am J Obstet Gynecol; 1993 Oct; 169(4):1065-70. PubMed ID: 8238121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renal dysgenesis in a monozygotic twin: association with in utero exposure to indomethacin.
    Restaino I; Kaplan BS; Kaplan P; Rosenberg HK; Witzleben C; Roberts N
    Am J Med Genet; 1991 Jun; 39(3):252-7. PubMed ID: 1867274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indomethacin treatment for polyhydramnios. Effective but potentially dangerous?
    Nordström L; Westgren M
    Acta Obstet Gynecol Scand; 1992 Apr; 71(3):239-41. PubMed ID: 1317651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Indomethacin therapy in hydramnios.
    Abhyankar S; Salvi VS
    J Postgrad Med; 2000; 46(3):176-8. PubMed ID: 11298464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Indomethacin tocolysis increases postnatal patent ductus arteriosus severity.
    Hammerman C; Glaser J; Kaplan M; Schimmel MS; Ferber B; Eidelman AI
    Pediatrics; 1998 Nov; 102(5):E56. PubMed ID: 9794986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of gestational age and fetal indomethacin levels on the incidence of constriction of the fetal ductus arteriosus.
    Van den Veyver IB; Moise KJ; Ou CN; Carpenter RJ
    Obstet Gynecol; 1993 Oct; 82(4 Pt 1):500-3. PubMed ID: 8377971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute renal failure in the neonate induced by the administration of indomethacin as a tocolytic agent.
    Pomeranz A; Korzets Z; Dolfin Z; Eliakim A; Bernheim J; Wolach B
    Nephrol Dial Transplant; 1996 Jun; 11(6):1139-41. PubMed ID: 8671983
    [No Abstract]   [Full Text] [Related]  

  • 29. Factors associated with permanent closure of the ductus arteriosus: a role for prolonged indomethacin therapy.
    Quinn D; Cooper B; Clyman RI
    Pediatrics; 2002 Jul; 110(1 Pt 1):e10. PubMed ID: 12093991
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of indomethacin tocolysis on fetal ductus arteriosus constriction with advancing gestational age.
    Vermillion ST; Scardo JA; Lashus AG; Wiles HB
    Am J Obstet Gynecol; 1997 Aug; 177(2):256-9; discussion 259-61. PubMed ID: 9290437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyhydramnios associated with a ring chromosome and low maternal serum alpha-fetoprotein levels managed with indomethacin.
    Kirshon B; Cotton DB
    Am J Obstet Gynecol; 1988 May; 158(5):1063-4. PubMed ID: 2453113
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indomethacin treatment for polyhydramnios and subsequent infantile nephrogenic diabetes insipidus.
    Smith LG; Kirshon B; Cotton DB
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 1):98-9. PubMed ID: 2197875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Balancing Benefits and Risks of Indomethacin in the Management of Antenatal Bartter Syndrome: A Case Report.
    Alajjuri OA; Samaha ME; Honemeyer U; Mohammed G; Mousa NA
    Front Med (Lausanne); 2022; 9():870503. PubMed ID: 35847797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term indomethacin therapy decreases fetal urine output and results in oligohydramnios.
    Kirshon B; Moise KJ; Mari G; Willis R
    Am J Perinatol; 1991 Mar; 8(2):86-8. PubMed ID: 2006947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Value and dangers of indomethacin used in pregnancy. Apropos of 304 treated patients].
    Marpeau L; Keskes J; Vincenti O; Boyer F; Bouillie J; Pigné A; Barrat J
    J Gynecol Obstet Biol Reprod (Paris); 1988; 17(1):115-22. PubMed ID: 3280651
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The fetal ductus arteriosus, a review.
    Brezinka C; Gittenberger-de Groot AC; Wladimiroff JW
    Zentralbl Gynakol; 1993; 115(10):423-32. PubMed ID: 8273432
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alteration of the amniotic fluid and neonatal outcome.
    Volante E; Gramellini D; Moretti S; Kaihura C; Bevilacqua G
    Acta Biomed; 2004; 75 Suppl 1():71-5. PubMed ID: 15301296
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fetal echocardiography during indomethacin treatment.
    Respondek M; Weil SR; Huhta JC
    Ultrasound Obstet Gynecol; 1995 Feb; 5(2):86-9. PubMed ID: 7719872
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Recurrent acute polyhydramnios treated with indomethacin].
    Faber BL
    S Afr Med J; 1990 Aug; 78(4):215-6. PubMed ID: 2200149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Consequences of delayed surgical closure of patent ductus arteriosus in very premature infants.
    Jaillard S; Larrue B; Rakza T; Magnenant E; Warembourg H; Storme L
    Ann Thorac Surg; 2006 Jan; 81(1):231-4. PubMed ID: 16368371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.